Study to Assess the Immunogenicity, Safety, and Efficacy of High Capacity Process Etanercept in Rheumatoid Arthritis Subjects
Clinical trial NCT02378506 · COMPLETED
Trial details
- NCT number
- NCT02378506
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2016-05-01
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.